XBP Europe (XBP) said Wednesday it finalized its acquisition of Exela Technologies BPA, a business process automation firm. It expects the deal to raise its annual revenue to over $900 million.
Shares of XBP advanced 85% as intraday trading volume surged to over 136 million from a daily average of about 65,000.
Super X AI Technology (SUPX) reported Wednesday the launch of its latest AI server, powered by Nvidia's (NVDA) Blackwell architecture GPU (B200).
Shares surged 43% as intraday trading volume catapulted to over 5.03 million from a daily average of roughly 83,000.
BioNexus Gene Lab (BGLC) and Fidelion Diagnostics said they are partnering for liquid biopsy cancer monitoring and artificial intelligence-driven biotechnology.
BioNexus will acquire an equity stake in Fidelion and secure an exclusive commercial rights to its VitaGuard minimal-residual-disease platform in Southeast-Asia as part of the deal deal.
Shares of BioNexus rose 41% as intraday trading volume soared to over 54.8 million from a daily average of about 1.1 million.
Price: 1.70, Change: +0.80, Percent Change: +88.86
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。